# Journal of Hepatology

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/journal-of-hepatology/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 4,950 |
| Citations | 1,136,450 |
| h-index | 381 |
| Homepage | https://www.journals.elsevier.com/journal-of-hepatology |
| Open Access | false |
| ISSN-L | 0168-8278 |
| ISSNs | 0168-8278,1600-0641 |
| OpenAlex ID | https://openalex.org/S83651209 |
| Publisher | Elsevier BV |
| Works | 58,137 |

## Journal papers

Showing 12 of 150.

- [EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection](https://scholariq.org/papers/easl-2017-clinical-practice-guidelines-on-the-management-of-hepatitis-b-virus/)
- [A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement](https://scholariq.org/papers/a-new-definition-for-metabolic-dysfunction-associated-fatty-liver-disease-an/)
- [NAFLD: A multisystem disease](https://scholariq.org/papers/nafld-a-multisystem-disease/)
- [EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis](https://scholariq.org/papers/easl-clinical-practice-guidelines-for-the-management-of-patients-with/)
- [A multisociety Delphi consensus statement on new fatty liver disease nomenclature](https://scholariq.org/papers/a-multisociety-delphi-consensus-statement-on-new-fatty-liver-disease-3/)
- [Baveno VII – Renewing consensus in portal hypertension](https://scholariq.org/papers/baveno-vii-renewing-consensus-in-portal-hypertension/)
- [Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030](https://scholariq.org/papers/modeling-nafld-disease-burden-in-china-france-germany-italy-japan-spain-united/)
- [EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)](https://scholariq.org/papers/easl-easd-easo-clinical-practice-guidelines-on-the-management-of-metabolic/)
- [Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis](https://scholariq.org/papers/non-alcoholic-fatty-liver-disease-and-risk-of-incident-cardiovascular-disease-a/)
- [COVID-19: Abnormal liver function tests](https://scholariq.org/papers/covid-19-abnormal-liver-function-tests/)
- [Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure](https://scholariq.org/papers/development-and-validation-of-a-prognostic-score-to-predict-mortality-in/)
- [The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease](https://scholariq.org/papers/the-mediterranean-diet-improves-hepatic-steatosis-and-insulin-sensitivity-in/)

## Journal top topics

Showing 8 of 25.

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Hepatitis B Virus Studies](https://scholariq.org/topics/hepatitis-b-virus-studies/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)
- [Liver physiology and pathology](https://scholariq.org/topics/liver-physiology-and-pathology/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.